177 related articles for article (PubMed ID: 21736733)
1. Molecular and cellular correlates of the CIITA-mediated inhibition of HTLV-2 Tax-2 transactivator function resulting in loss of viral replication.
Orlandi C; Forlani G; Tosi G; Accolla RS
J Transl Med; 2011 Jul; 9():106. PubMed ID: 21736733
[TBL] [Abstract][Full Text] [Related]
2. The Major Histocompatibility Complex Class II Transactivator CIITA Inhibits the Persistent Activation of NF-κB by the Human T Cell Lymphotropic Virus Type 1 Tax-1 Oncoprotein.
Forlani G; Abdallah R; Accolla RS; Tosi G
J Virol; 2016 Jan; 90(7):3708-21. PubMed ID: 26792751
[TBL] [Abstract][Full Text] [Related]
3. Major histocompatibility complex class II transactivator CIITA is a viral restriction factor that targets human T-cell lymphotropic virus type 1 Tax-1 function and inhibits viral replication.
Tosi G; Forlani G; Andresen V; Turci M; Bertazzoni U; Franchini G; Poli G; Accolla RS
J Virol; 2011 Oct; 85(20):10719-29. PubMed ID: 21813598
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of human T cell leukemia virus type 2 replication by the suppressive action of class II transactivator and nuclear factor Y.
Tosi G; Pilotti E; Mortara L; De Lerma Barbaro A; Casoli C; Accolla RS
Proc Natl Acad Sci U S A; 2006 Aug; 103(34):12861-6. PubMed ID: 16908858
[TBL] [Abstract][Full Text] [Related]
5. The MHC class II transcriptional activator (CIITA) inhibits HTLV-2 viral replication by blocking the function of the viral transactivator Tax-2.
Casoli C; De Lerma Barbaro A; Pilotti E; Bertazzoni U; Tosi G; Accolla RS
Blood; 2004 Feb; 103(3):995-1001. PubMed ID: 14525769
[TBL] [Abstract][Full Text] [Related]
6. Human T-Cell Lymphotropic Virus Type 1 Transactivator Tax Exploits the XPB Subunit of TFIIH during Viral Transcription.
Martella C; Tollenaere AI; Waast L; Lacombe B; Groussaud D; Margottin-Goguet F; Ramirez BC; Pique C
J Virol; 2020 Mar; 94(8):. PubMed ID: 32024775
[TBL] [Abstract][Full Text] [Related]
7. The MHC-II transactivator CIITA inhibits Tat function and HIV-1 replication in human myeloid cells.
Forlani G; Turrini F; Ghezzi S; Tedeschi A; Poli G; Accolla RS; Tosi G
J Transl Med; 2016 Apr; 14():94. PubMed ID: 27089879
[TBL] [Abstract][Full Text] [Related]
8. The MHC-II transactivator CIITA, a restriction factor against oncogenic HTLV-1 and HTLV-2 retroviruses: similarities and differences in the inhibition of Tax-1 and Tax-2 viral transactivators.
Forlani G; Abdallah R; Accolla RS; Tosi G
Front Microbiol; 2013; 4():234. PubMed ID: 23986750
[TBL] [Abstract][Full Text] [Related]
9. Characterizing the Interaction between the HTLV-1 Transactivator Tax-1 with Transcription Elongation Factor ELL2 and Its Impact on Viral Transactivation.
Kohrt S; Strobel S; Mann MC; Sticht H; Fleckenstein B; Thoma-Kress AK
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948391
[TBL] [Abstract][Full Text] [Related]
10. Histone deacetylase 1/mSin3A disrupts gamma interferon-induced CIITA function and major histocompatibility complex class II enhanceosome formation.
Zika E; Greer SF; Zhu XS; Ting JP
Mol Cell Biol; 2003 May; 23(9):3091-102. PubMed ID: 12697811
[TBL] [Abstract][Full Text] [Related]
11. Novel Interactions between the Human T-Cell Leukemia Virus Type 1 Antisense Protein HBZ and the SWI/SNF Chromatin Remodeling Family: Implications for Viral Life Cycle.
Alasiri A; Abboud Guerr J; Hall WW; Sheehy N
J Virol; 2019 Aug; 93(16):. PubMed ID: 31142665
[TBL] [Abstract][Full Text] [Related]
12. CIITA leucine-rich repeats control nuclear localization, in vivo recruitment to the major histocompatibility complex (MHC) class II enhanceosome, and MHC class II gene transactivation.
Hake SB; Masternak K; Kammerbauer C; Janzen C; Reith W; Steimle V
Mol Cell Biol; 2000 Oct; 20(20):7716-25. PubMed ID: 11003667
[TBL] [Abstract][Full Text] [Related]
13. Interaction of HTLV-1 Tax protein with calreticulin: implications for Tax nuclear export and secretion.
Alefantis T; Flaig KE; Wigdahl B; Jain P
Biomed Pharmacother; 2007 May; 61(4):194-200. PubMed ID: 17395420
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CREB- and NF-kappaB-mediated transactivation by human T lymphotropic virus type II (HTLV-II) and type I (HTLV-I) tax proteins.
Lewis MJ; Sheehy N; Salemi M; VanDamme AM; Hall WW
Virology; 2002 Mar; 295(1):182-9. PubMed ID: 12033776
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of nuclear import and export that control the subcellular localization of class II transactivator.
Cressman DE; O'Connor WJ; Greer SF; Zhu XS; Ting JP
J Immunol; 2001 Oct; 167(7):3626-34. PubMed ID: 11564775
[TBL] [Abstract][Full Text] [Related]
16. Suppression of HTLV-1 replication by Tax-mediated rerouting of the p13 viral protein to nuclear speckles.
Andresen V; Pise-Masison CA; Sinha-Datta U; Bellon M; Valeri V; Washington Parks R; Cecchinato V; Fukumoto R; Nicot C; Franchini G
Blood; 2011 Aug; 118(6):1549-59. PubMed ID: 21677314
[TBL] [Abstract][Full Text] [Related]
17. Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1.
Forlani G; Shallak M; Ramia E; Tedeschi A; Accolla RS
Retrovirology; 2019 Nov; 16(1):34. PubMed ID: 31783769
[TBL] [Abstract][Full Text] [Related]
18. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
[TBL] [Abstract][Full Text] [Related]
19. The human T cell leukemia/lymphotropic virus type 1 Tax protein represses MyoD-dependent transcription by inhibiting MyoD-binding to the KIX domain of p300. A potential mechanism for Tax-mediated repression of the transcriptional activity of basic helix-loop-helix factors.
Riou P; Bex F; Gazzolo L
J Biol Chem; 2000 Apr; 275(14):10551-60. PubMed ID: 10744749
[TBL] [Abstract][Full Text] [Related]
20. The tax protein from the primate T-cell lymphotropic virus type 3 is expressed in vivo and is functionally related to HTLV-1 Tax rather than HTLV-2 Tax.
Chevalier SA; Meertens L; Pise-Masison C; Calattini S; Park H; Alhaj AA; Zhou M; Gessain A; Kashanchi F; Brady JN; Mahieux R
Oncogene; 2006 Jul; 25(32):4470-82. PubMed ID: 16532031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
